Business
Why the Mesoblast (ASX:MSB) share price is sinking 11% lower – The Motley Fool Australia
The Mesoblast limited (ASX:MSB) share price is sinking lower on Tuesday. Here’s what you need to know…
The Mesoblast limited(ASX: MSB) share price has come under pressure on Tuesday after the release of an announcement.
At the time of writing the allogeneic cellular medicines developer’s shares are down 11% to $4.03.
What did Mesoblast announce?
This morning Mesoblast announced the top-line results from the landmark DREAM-HF Phase 3 randomised controlled trial of its allogeneic cell therapy rexlemestrocel-L (REVASCOR) in 537 patients with advanced chronic heart failure.
According to the release,…
-
Noosa News5 hours agoShocking moment Bradley Donald Towle arrested after Bruce Hwy rampage and shooting on Sunshine coast
-
General6 hours agoNSW Police to provide update on Sydney woman’s kidnap from Bankstown home and killing
-
General21 hours agoPope Francis, the 266th pope, has died
-
General19 hours agoFounder Schwab quits as World Economic Forum chair